Barisic will transition from current role as Chief Financial and Administrative Officer in January 2023
Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab
|
4 min read
New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease
|
3 min read
Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2
|
6 min read
White will be the first person living with CF to lead the Board into a new era of CF
|
5 min read